Ledger.Open graph →
SEC Form D · filed October 11, 2024

Evida Biosciences Inc

Offering
$42.0M
Sold
$42.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
San Diego, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Mark L. Gleiberman · San Diego, CAExec · DirectorScott Glenn · San Diego, CADirectorMichael Walsh · San Diego, CAExec · DirectorLauren Otsuki · San Diego, CADirectorRolf Benirschke · San Diego, CADirectorShierley Widjaja · San Diego, CADirectorDavid Wrigley · San Diego, CADirectorBrian G. Feagan, M.D · San Diego, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗